-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
February 16, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
November 04, 2021 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
June 01, 2022 - Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3
Systematic Review on Opioid
Treatments for Chronic Pain:
Surveillance Report 3
Literature Update Period: December 2021 to March 16 2022
Background and Purpose
This is the third and final surveillance report for the 2020 report Opioid…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rti-item-bank-bias-precision_research.pdf
September 01, 2011 - Development of the RTI Item Bank on Risk of Bias and Precision of Observational Studies
Methods Research Report
Development of the RTI Item Bank on Risk of Bias
and Precision of Observational Studies
Methods Research Report
Development of the RTI Item Bank on Risk of…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/opioid-chronic-pain-surveillance-report-3.pdf
June 01, 2022 - Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3
1
Systematic Review on Opioid
Treatments for Chronic Pain:
Surveillance Report 3
Literature Update Period: December 2021 to March 16 2022
Background and Purpose
This is the third and final surveillance report for the 2020 report …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-e1.xlsx
March 13, 2023 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/draft-living-review-plant-chronic-pain-e-evidence-tables.xlsx
March 25, 2024 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - Comparative Effectiveness Review
118
Appendix A. Pharmacokinetics, Indications and
Dosing of Included Drugs
Drug and Trade
Name
(Trade names
provided only for
drugs under
patent.)
Half-life or other
relevant
pharmacokinetic
feature
Labeled indications Dosing (oral
doses)
Dose adjustments fo…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_executive.pdf
November 01, 2012 - 1
Comparative Effectiveness Review
Number 77
Physical Therapy Interventions for Knee Pain
Secondary to Osteoarthritis
Executive Summary
Background
Osteoarthritis (OA), the most common
form of arthritis,1 is a progressive joint
disorder characterized by gradual loss
of cartilage.2 Osteoarthritis of the knee …